Skip to main content

Colorado BioScience Association, Montgomery County Department of Economic Development, Tech Council of Maryland, Science Foundation Ireland, BayBio, Buffalo Niagara Medical Campus

Premium

Science Foundation Ireland Announces €60.25M in Biotech Industry-Academic Awards
 
Science Foundation Ireland said earlier this month it would invest €60.25 million ($88.4 million) in eight biotech industry-academic projects in five universities, part of a total €87 million ($127.6 million) invested in various technologies in 11 academic institutions across Ireland. The award is the largest made by SFI under its Centers for Science, Engineering and Technology, and its Strategic Research Clusters programs.
 
The awards will support one CSET and twelve SRCs. In total, 490 senior researchers, post-doctoral researchers and PhD students will participate in the projects, which also involve partnerships with 48 companies.
 
Micheál Martin, Ireland’s minister for enterprise, trade and employment, said in a statement the awards followed assessment of applicants by a panel of 50 international scientific experts. He said the research reflected a commitment to funding research articulated in the government’s Strategy for Science Technology and Innovation 2006-2013.
 
Approved for a CSET award of €16.85 million over 60 months was Joseph van Genabith of Dublin City University, for next-generation localization.
 
Approved biotech SRCs over 60 months:
  • €7.4 million to Alexander Evans, University College Dublin, for Reproductive Biology Research Cluster.
  • €5.3 million to UCD’s David Brayden for Irish Drug Delivery Research Network.
  • Nearly €7 million to Kieran Hodnett, University of Limerick, for Solid State Pharmaceuticals Cluster.
  • €7.2 million to UCD’s Kenneth Dawson for BioNanoInteract.
  • €4.3 million to Abhay Pandit , National University of Ireland, Galway, for Network of Excellence for Functional Biomaterials.
  • €7.5 million to Kingston Mills, Trinity College, Dublin, for Immunology Research Center.
  • €4.7 million to UCD’s James MacElroy for Advanced Biomimetics for Solar Energy Conversion.

BayBio Launching VC Series, Golf Tournament, Breakfast Meeting Series for 2008

BayBio, the Northern California life sciences association, said it will launch in 2008 a new series of breakfast meetings focused on therapeutics and medical devices, while its BayBio Institute will launch a new Venture Spotlight series as well as a new golf tournament in May.

In addition, BayBio said, it will expand its Executive Series of talks by top life sciences executives and its Gene Acres tours, with the intent of providing more insight into the latest developments at top companies and increased opportunities for members and others to see first-hand the region’s newest life sciences facilities and their innovations.

BayBio will continue its quarterly BayBioSolutions seminars, as well as marquee events such as its annual Pantheon Awards ceremony, and its BayBio and Gene Acres annual conferences.


Buffalo Niagara Medical Campus Studies Options for Newly Acquired Trico Property

The Buffalo Niagara Medical Campus will update its master plan to incorporate into its strategy for future growth the 15-acre former Trico Products complex, to which it took title Nov. 14 — nearly two months after it submitted the winning $4.3 million bid for the site at a US Bankruptcy Court auction.

BNMC Executive Director Matthew Enstice told the Buffalo News the industrial site offered new development possibilities for the adjacent downtown Buffalo biotechnology campus, which over the past six years had grown as much as had been projected to occur within 10 years: “This additional space presents a significant opportunity to grow a knowledge-based economy in Buffalo and we will work proactively to make that happen.”

BNMC has contracted with Chan Krieger and Associates of Cambridge, Mass., to update the growth blueprint. The firm had developed the campus’ original 100- acre master plan in 2002.

The former Trico windshield wiper plant — bordered by Goodell, Washington, Ellicott and Virginia streets — is across Virginia from the southern edge of current medical campus perimeter. Completed in 1935, the plant consists of a 540,000-square-foot, six-story building, and a four-story structure of more than 100,000 square feet. Both buildings have state and national historical landmark status, and are served by a 5.3-acre parking lot within the property.

Short-term plans call for renovating some 80,000 square feet of space in the smaller building for biotech ventures. With that project in mind, the medical campus has applied for a $6.5 million “Restore NY” grant from the state Empire State Development Corp. Long term, the building requires immediate roof line and brick repairs as well as environmental remediation, Buffalo’s economic development chief Richard Tobe told the News.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.